Redmile Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Redmile Group’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,000	Closed	-$25K	–	60
2016 Q1	$25K	Sell	10,000 -53,189	-84%	-$194K	﹤0.01%	47
2015 Q4	$512K	Sell	63,189 -437,426	-87%	-$3.1M	0.04%	48
2015 Q3	$3.03M	Buy	500,615 +24,322	+5%	+$176K	0.23%	45
2015 Q2	$3.92M	Buy	476,293 +458,793	+2,622%	+$3.64M	0.32%	47
2015 Q1	$132K	Buy	+17,500	New	+$137K	0.01%	54
2013 Q3	–	Sell	-255,100	Closed	-$3.61M	–	63
2013 Q2	$3.61M	Buy	+255,100	New	+$3.31M	0.64%	37

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Redmile Group's CCXI Position: Q2 2016 in Review

Redmile Group sold out of ChemoCentryx, Inc. (CCXI) in Q2 2016, closing a stake of 10,000 shares — an estimated $25K sold.

Redmile Group first reported a position in CCXI in Q2 2013 and held it in 6 quarters. The position peaked at $3.92M in Q2 2015. 77 funds tracked by Wall St. Rank hold CCXI as of Q2 2016.

Redmile Group reported no remaining ChemoCentryx, Inc. position as of Q2 2016 after selling out during the quarter.
Redmile Group sold 10,000 ChemoCentryx, Inc. shares in Q2 2016, an estimated $25K.
Redmile Group first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 6 quarters.
Redmile Group's ChemoCentryx, Inc. position peaked at $3.92M in Q2 2015.
77 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2016.

Based on Redmile Group's 13F filing for Q2 2016, filed 16 Aug 2016.